We don’t have all the answers and there's no cure yet, but better treatments are emerging.
Researchers across the world are seeking to understand myeloproliferative disorders – what causes MPDs, how we can treat them, and ultimately how we can cure these conditions.
The discovery of the JAK2 mutation in 2005 catapulted MPD science forward. We now believe that genetic mutations acquired in adulthood (or more rarely in childhood) may damage the bone marrow’s ability to manufacture blood cells. The JAK2 mutation is one change that can occur.
New drugs under trial such as JAK2 inhibitors are showing promise in treating MF, PV and ET.
Researching are uncovering the mysteries behind the genetic mutations we believe may cause MPDs.
Find links to info on haematology news and clinical trials for MPDs as well as healthy living and more.
Information to support you in your practice - for haematologists, GPS, nurses and pharmacists.